Cargando…

A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans

Just as Koch’s postulates formed the foundation of early infectious disease study, Stanley Falkow’s molecular Koch’s postulates define best practice in determining whether a specific gene contributes to virulence of a pathogen. Fundamentally, these molecular postulates state that if a gene is involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Arras, Samantha D. M., Chitty, Jessica L., Blake, Kirsten L., Schulz, Benjamin L., Fraser, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391909/
https://www.ncbi.nlm.nih.gov/pubmed/25856300
http://dx.doi.org/10.1371/journal.pone.0122916
_version_ 1782365894632013824
author Arras, Samantha D. M.
Chitty, Jessica L.
Blake, Kirsten L.
Schulz, Benjamin L.
Fraser, James A.
author_facet Arras, Samantha D. M.
Chitty, Jessica L.
Blake, Kirsten L.
Schulz, Benjamin L.
Fraser, James A.
author_sort Arras, Samantha D. M.
collection PubMed
description Just as Koch’s postulates formed the foundation of early infectious disease study, Stanley Falkow’s molecular Koch’s postulates define best practice in determining whether a specific gene contributes to virulence of a pathogen. Fundamentally, these molecular postulates state that if a gene is involved in virulence, its removal will compromise virulence. Likewise, its reintroduction should restore virulence to the mutant. These approaches are widely employed in Cryptococcus neoformans, where gene deletion via biolistic transformation is a well-established technique. However, the complementation of these mutants is less straightforward. Currently, one of three approaches will be taken: the gene is reintroduced at the original locus, the gene is reintroduced into a random site in the genome, or the mutant is not complemented at all. Depending on which approach is utilized, the mutant may be complemented but other genes are potentially disrupted in the process. To counter the drawbacks of the current approaches to complementation we have created a new tool to assist in this key step in the study of a gene’s role in virulence. We have identified and characterized a small gene-free region in the C. neoformans genome dubbed the “safe haven”, and constructed a plasmid vector that targets DNA constructs to this preselected site. The plasmid vector integrates with high frequency, effectively complementing a mutant strain without disrupting adjacent genes. qRT-PCR of the flanking genes on either side of the safe haven site following integration of the targeting vector revealed no changes in their expression, and no secondary phenotypes were observed in a range of phenotypic assays including an intranasal murine infection model. Combined, these data confirm that we have successfully created a much-needed molecular resource for the Cryptococcus community, enabling the reliable fulfillment of the molecular Koch’s postulates.
format Online
Article
Text
id pubmed-4391909
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43919092015-04-21 A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans Arras, Samantha D. M. Chitty, Jessica L. Blake, Kirsten L. Schulz, Benjamin L. Fraser, James A. PLoS One Research Article Just as Koch’s postulates formed the foundation of early infectious disease study, Stanley Falkow’s molecular Koch’s postulates define best practice in determining whether a specific gene contributes to virulence of a pathogen. Fundamentally, these molecular postulates state that if a gene is involved in virulence, its removal will compromise virulence. Likewise, its reintroduction should restore virulence to the mutant. These approaches are widely employed in Cryptococcus neoformans, where gene deletion via biolistic transformation is a well-established technique. However, the complementation of these mutants is less straightforward. Currently, one of three approaches will be taken: the gene is reintroduced at the original locus, the gene is reintroduced into a random site in the genome, or the mutant is not complemented at all. Depending on which approach is utilized, the mutant may be complemented but other genes are potentially disrupted in the process. To counter the drawbacks of the current approaches to complementation we have created a new tool to assist in this key step in the study of a gene’s role in virulence. We have identified and characterized a small gene-free region in the C. neoformans genome dubbed the “safe haven”, and constructed a plasmid vector that targets DNA constructs to this preselected site. The plasmid vector integrates with high frequency, effectively complementing a mutant strain without disrupting adjacent genes. qRT-PCR of the flanking genes on either side of the safe haven site following integration of the targeting vector revealed no changes in their expression, and no secondary phenotypes were observed in a range of phenotypic assays including an intranasal murine infection model. Combined, these data confirm that we have successfully created a much-needed molecular resource for the Cryptococcus community, enabling the reliable fulfillment of the molecular Koch’s postulates. Public Library of Science 2015-04-09 /pmc/articles/PMC4391909/ /pubmed/25856300 http://dx.doi.org/10.1371/journal.pone.0122916 Text en © 2015 Arras et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Arras, Samantha D. M.
Chitty, Jessica L.
Blake, Kirsten L.
Schulz, Benjamin L.
Fraser, James A.
A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans
title A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans
title_full A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans
title_fullStr A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans
title_full_unstemmed A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans
title_short A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans
title_sort genomic safe haven for mutant complementation in cryptococcus neoformans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391909/
https://www.ncbi.nlm.nih.gov/pubmed/25856300
http://dx.doi.org/10.1371/journal.pone.0122916
work_keys_str_mv AT arrassamanthadm agenomicsafehavenformutantcomplementationincryptococcusneoformans
AT chittyjessical agenomicsafehavenformutantcomplementationincryptococcusneoformans
AT blakekirstenl agenomicsafehavenformutantcomplementationincryptococcusneoformans
AT schulzbenjaminl agenomicsafehavenformutantcomplementationincryptococcusneoformans
AT fraserjamesa agenomicsafehavenformutantcomplementationincryptococcusneoformans
AT arrassamanthadm genomicsafehavenformutantcomplementationincryptococcusneoformans
AT chittyjessical genomicsafehavenformutantcomplementationincryptococcusneoformans
AT blakekirstenl genomicsafehavenformutantcomplementationincryptococcusneoformans
AT schulzbenjaminl genomicsafehavenformutantcomplementationincryptococcusneoformans
AT fraserjamesa genomicsafehavenformutantcomplementationincryptococcusneoformans